COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO).
Where this comes from
- Record sourced from PubMed, PMID 32413527.
- Also identified by DOI 10.1016/j.radonc.2020.04.061 and PMC identifier 7215158.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Italy experienced one of the world's deadliest COVID-19 outbreaks and healthcare systems had to instantly reorganise activity. The Italian Radiation Oncology Departments adapted numerous solutions to minimize the disruptions. Information technologies, treatment prioritization and implementation of hypofractionation and protection procedures allowed balancing between cancer patient care and patient/healthcare workers safety.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Medical Oncology
- Neoplasms
- Pandemics
- Pneumonia, Viral